Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025

Radiological Response and Characteristics of Patients Diagnosed With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: An Observational Study.

View Full Paper
Ask AI
Bookmark
Share

Authors

VBValeska Almeida BritoDAD.C.B.L. ArouchaAAAndressa Maranhão de Arruda

Discussion

Loading...

Member takes

Overview

Observational study identifies key factors affecting radiological response to TACE in patients with hepatocellular carcinoma, suggesting implications for treatment strategies.

Key Points

  • Patients undergoing transarterial chemoembolization showed a significant reduction in lesion size, indicating treatment effectiveness.
  • Only 38.2% of patients responded positively after the first TACE, signaling the need for further evaluation in treatment approaches.
  • HCV etiology emerged as a factor linked to improved treatment response, highlighting its role in therapeutic outcomes.
  • The study underscores the significance of cirrhosis staging in predicting response to TACE for hepatocellular carcinoma patients.

Cite This Study

Brito et al. (2025) studied this question.

synapsesocial.com/papers/68de5d9383cbc991d0a1feebhttps://doi.org/10.1155/ijh/5821839
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Objective Response by mRECIST is an Independent Prognostic Factor for Overall Survival in Intermediate Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization2025
  2. 2Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug-Eluting Beads2015 · 2 citations
  3. 3Efficacy and Safety of Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma (HCC) and Assessment of Health Related Quality of Life (HRQoL) using CLDQ©2024
  4. 4Cardiopulmonary assessment of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization2021 · 3 citations
  5. 5Study of different outcomes and their predictive factors of trans-arterial che-moembolization in patients with hepatocellular carcinoma2024